Plan comparison of volumetric-modulated arc therapy (RapidArc) and conventional intensity-modulated radiation therapy (IMRT) in anal canal cancer

Radiation Oncology

Volumn 5, Issue 1, 2010, Pages

  Vieillot, Sabine ^a   Azria, David ^a   Lemanski, Claire ^a   Moscardo, Carmen L ^a   Gourgou, Sophie ^a   Dubois, Jean Bernard ^a   Aillères, Norbert ^a   Fenoglietto, Pascal ^a  

^a CENTRE VAL D AURELLE   (France)

Author keywords

[No Author keywords available]

Indexed keywords

ANAL CANAL; ANUS CANCER; ARTICLE; BLADDER; CANCER RADIOTHERAPY; CLINICAL ARTICLE; COMPARATIVE STUDY; CONTROLLED STUDY; FEMUR HEAD; GENITAL SYSTEM; HUMAN; ILIAC CREST; INTENSITY MODULATED RADIATION THERAPY; INTESTINE; PERINEUM; RADIATION DOSE; RADIATION DOSE DISTRIBUTION; TREATMENT PLANNING; VOLUMETRY; ANUS TUMOR; CANCER STAGING; CARCINOMA; COMPUTER ASSISTED RADIOTHERAPY; METHODOLOGY; ORGANS AT RISK; PATHOLOGY; RADIATION EXPOSURE; RADIOMETRY;

ANUS NEOPLASMS; CARCINOMA; HUMANS; NEOPLASM STAGING; ORGANS AT RISK; RADIOMETRY; RADIOTHERAPY PLANNING, COMPUTER-ASSISTED; RADIOTHERAPY, INTENSITY-MODULATED;

EID: 77957729067     PISSN: None     EISSN: 1748717X     Source Type: Journal    
DOI: 10.1186/1748-717X-5-92     Document Type: Article

References (36)

1. UKCCCR Anal Cancer Trial Working Party. UK Co-ordinating Comittee on Cancer Research Epidermoid anal cancer: results from the UKCCCR randomised trial of radiotherapy alone versus radiotherapy, 5-fluorouracil, and mitomycin. Lancet 1996, 348:1049-1054. 10.1016/S0140-6736(96)03409-5, 8874455, UKCCCR Anal Cancer Trial Working Party. UK Co-ordinating Comittee on Cancer Research.
2. Bartelink H, Roelofsen F, Eschwege F, Rougier P, Bosset JF, Gonzalez DG, Peiffert D, van Glabbeke M, Pierart M. Concomitant radiotherapy and chemotherapy is superior to radiotherapy alone in the treatment of locally advanced anal cancer: results of a phase III randomized trial of the European Organization for Research and Treatment of Cancer Radiotherapy and Gastrointestinal Cooperative Groups. J Clin Oncol 1997, 15:2040-2049.
3. Flam M, John M, Pajak TF, Petrelli N, Myerson R, Doggett S, Quivey J, Rotman M, Kerman H, Coia L, et al. Role of mitomycin in combination with fluorouracil and radiotherapy, and of salvage chemoradiation in the definitive nonsurgical treatment of epidermoid carcinoma of the anal canal: results of a phase III randomized intergroup study. J Clin Oncol 1996, 14:2527-2539.
4. Intensity modulated radiation therapy collaborative working group Intensity modulated radiotherapy: current status and issues of interest. Int J Radiat Oncol Biol Phys 2001, 51:880-914. Intensity modulated radiation therapy collaborative working group.
5. Menkarios C, Azria D, Laliberte B, Moscardo CL, Gourgou S, Lemanski C, Dubois JB, Ailleres N, Fenoglietto P. Optimal organ-sparing intensity-modulated radiation therapy (IMRT) regimen for the treatment of locally advanced anal canal carcinoma: a comparison of conventional and IMRT plans. Radiat Oncol 2007, 2:41. 10.1186/1748-717X-2-41, 2204019, 18005443.
6. Hodges JC, Das P, Eng C, Reish AG, Beddar AS, Delclos ME, Krishnan S, Crane CH. Intensity-Modulated Radiation Therapy for the Treatment of Squamous Cell Anal Cancer with Para-aortic Nodal Involvement. Int J Radiat Oncol Biol Phys 2009, 75:791-794.
7. Milano MT, Jani AB, Farrey KJ, Rash C, Heimann R, Chmura SJ. Intensity-modulated radiation therapy (IMRT) in the treatment of anal cancer: toxicity and clinical outcome. Int J Radiat Oncol Biol Phys 2005, 63:354-361.
8. Salama JK, Mell LK, Schomas DA, Miller RC, Devisetty K, Jani AB, Mundt AJ, Roeske JC, Liauw SL, Chmura SJ. Concurrent chemotherapy and intensity-modulated radiation therapy for anal canal cancer patients: a multicenter experience. J Clin Oncol 2007, 25:4581-4586. 10.1200/JCO.2007.12.0170, 17925552.
9. Devisetty K, Mell LK, Salama JK, Schomas DA, Miller RC, Jani AB, Roeske JC, Aydogan B, Chmura SJ. A multi-institutional acute gastrointestinal toxicity analysis of anal cancer patients treated with concurrent intensity-modulated radiation therapy (IMRT) and chemotherapy. Radiother Oncol 2009, 93:298-301. 10.1016/j.radonc.2009.07.006, 19717198.
10. Pepek JMWCG, Clough RW, Wu QJ, Yoo S, Czito BG. Intensity Modulated Radiation Therapy (IMRT) for Anal Cancer: The Duke University Experience. Int J Radiat Oncol Biol Phys 2009, S 2191.
11. Otto K. Volumetric modulated arc therapy: IMRT in a single gantry arc. Med Phys 2008, 35:310-317. 10.1118/1.2818738, 18293586.
12. Ling CC, Zhang P, Archambault Y, Bocanek J, Tang G, Losasso T. Commissioning and quality assurance of RapidArc radiotherapy delivery system. Int J Radiat Oncol Biol Phys 2008, 72:575-581.
13. Greene FL, Page DL, Fleming ID, Fritz A, Balch CM, Haller DG, Morrow M, . (eds) AJCC: Cancer staging manual. New York 2002, 6, (eds).
14. Clivio A, Fogliata A, Franzetti-Pellanda A, Nicolini G, Vanetti E, Wyttenbach R, Cozzi L. Volumetric-modulated arc radiotherapy for carcinomas of the anal canal: A treatment planning comparison with fixed field IMRT. Radiother Oncol 2009, 92:118-24. 10.1016/j.radonc.2008.12.020, 19181409.
15. Fogliata A, Clivio A, Nicolini G, Vanetti E, Cozzi L. Intensity modulation with photons for benign intracranial tumours: a planning comparison of volumetric single arc, helical arc and fixed gantry techniques. Radiother Oncol 2008, 89:254-262. 10.1016/j.radonc.2008.07.021, 18760851.
16. Palma D, Vollans E, James K, Nakano S, Moiseenko V, Shaffer R, McKenzie M, Morris J, Otto K. Volumetric modulated arc therapy for delivery of prostate radiotherapy: comparison with intensity-modulated radiotherapy and three-dimensional conformal radiotherapy. Int J Radiat Oncol Biol Phys 2008, 72:996-1001.
17. Alexander AS, Wells D, Berrang T, Parsons C, Mydin A, Shaffer R, Wong F, Sayers D, Otto K. Volumetric arc therapy (VMAT) reduces treatment time compared to conventional IMRT (cIMRT) while maintaining similar plan quality in whole pelvic gynecologic radiotherapy. Int J Radiat Oncol Biol Phys 2008, 72:S366.
18. Vanetti E, Clivio A, Nicolini G, Fogliata A, Ghosh-Laskar S, Agarwal JP, Upreti RR, Budrukkar A, Murthy V, Deshpande DD, et al. Volumetric modulated arc radiotherapy for carcinomas of the oro-pharynx, hypo-pharynx and larynx: A treatment planning comparison with fixed field IMRT. Radiother Oncol 2009, 92:111-117. 10.1016/j.radonc.2008.12.008, 19157609.
19. Popescu CC, Olivotto IA, Beckham WA, Ansbacher W, Zavgorodni S, Shaffer R, Wai ES, Otto K. Volumetric Modulated Arc Therapy Improves Dosimetry and Reduces Treatment Time Compared To Conventional Intensity-Modulated Radiotherapy for Locoregional Radiotherapy of Left-Sided Breast Cancer and Internal Mammary Nodes. Int J Radiat Oncol Biol Phys 2010, 76:287-95.
20. Shaffer R, Nichol AM, Vollans E, Fong M, Nakano S, Moiseenko V, Schmuland M, Ma R, McKenzie M, Otto K. A Comparison of Volumetric Modulated Arc Therapy and Conventional Intensity-Modulated Radiotherapy for Frontal and Temporal High-Grade Gliomas. Int J Radiat Oncol Biol Phys 2009,
21. Wagner D, Christiansen H, Wolff H, Vorwerk H. Radiotherapy of malignant gliomas: Comparison of volumetric single arc technique (RapidArc), dynamic intensity-modulated technique and 3D conformal technique. Radiother Oncol 2009, 93:593-596. 10.1016/j.radonc.2009.10.002, 19897266.
22. Wolff D, Stieler F, Welzel G, Lorenz F, Abo-Madyan Y, Mai S, Herskind C, Polednik M, Steil V, Wenz F, et al. Volumetric modulated arc therapy (VMAT) vs. serial tomotherapy, step-and-shoot IMRT and 3D-conformal RT for treatment of prostate cancer. Radiother Oncol 2009, 93:226-233. 10.1016/j.radonc.2009.08.011, 19765846.
23. Taylor A, Rockall AG, Reznek RH, Powell ME. Mapping pelvic lymph nodes: guidelines for delineation in intensity-modulated radiotherapy. Int J Radiat Oncol Biol Phys 2005, 63:1604-1612. 10.1016/j.ijrobp.2005.05.062, 16198509.
24. Gallagher MJ, Brereton HD, Rostock RA, Zero JM, Zekoski DA, Poyss LF, Richter MP, Kligerman MM. A prospective study of treatment techniques to minimize the volume of pelvic small bowel with reduction of acute and late effects associated with pelvic irradiation. Int J Radiat Oncol Biol Phys 1986, 12:1565-1573.
25. Mell LK, Kochanski JD, Roeske JC, Haslam JJ, Mehta N, Yamada SD, Hurteau JA, Collins YC, Lengyel E, Mundt AJ. Dosimetric predictors of acute hematologic toxicity in cervical cancer patients treated with concurrent cisplatin and intensity-modulated pelvic radiotherapy. Int J Radiat Oncol Biol Phys 2006, 66:1356-1365.
26. Mell LK, Schomas DA, Salama JK, Devisetty K, Aydogan B, Miller RC, Jani AB, Kindler HL, Mundt AJ, Roeske JC, et al. Association between bone marrow dosimetric parameters and acute hematologic toxicity in anal cancer patients treated with concurrent chemotherapy and intensity-modulated radiotherapy. Int J Radiat Oncol Biol Phys 2008, 70:1431-1437.
27. Mell LK, Tiryaki H, Ahn KH, Mundt AJ, Roeske JC, Aydogan B. Dosimetric comparison of bone marrow-sparing intensity-modulated radiotherapy versus conventional techniques for treatment of cervical cancer. Int J Radiat Oncol Biol Phys 2008, 71:1504-1510.
28. RTOG 0529: A phase II evaluation of dose-painted IMRT in combination with 5-fluorouracil and mitomycin-C for reduction of acute morbidity in carcinoma of the anal canal. , http://rtog.org/members/protocols/0529/0529.pdf
29. Emami B, Lyman J, Brown A, Coia L, Goitein M, Munzenrider JE, Shank B, Solin LJ, Wesson M. Tolerance of normal tissue to therapeutic irradiation. Int J Radiat Oncol Biol Phys 1991, 21:109-122.
30. Cozzi L, Dinshaw KA, Shrivastava SK, Mahantshetty U, Engineer R, Deshpande DD, Jamema SV, Vanetti E, Clivio A, Nicolini G, et al. A treatment planning study comparing volumetric arc modulation with RapidArc and fixed field IMRT for cervix uteri radiotherapy. Radiother Oncol 2008, 89:180-191. 10.1016/j.radonc.2008.06.013, 18692929.
31. Shibamoto Y, Ito M, Sugie C, Ogino H, Hara M. Recovery from sublethal damage during intermittent exposures in cultured tumor cells: implications for dose modification in radiosurgery and IMRT. Int J Radiat Oncol Biol Phys 2004, 59:1484-1490.
32. Wang JZ, Li XA, D'Souza WD, Stewart RD. Impact of prolonged fraction delivery times on tumor control: a note of caution for intensity-modulated radiation therapy (IMRT). Int J Radiat Oncol Biol Phys 2003, 57:543-552. 10.1016/S0360-3016(03)00499-1, 12957268.
33. Randall ME, Ibbott GS. Intensity-modulated radiation therapy for gynecologic cancers: pitfalls, hazards, and cautions to be considered. Semin Radiat Oncol 2006, 16:138-143. 10.1016/j.semradonc.2006.02.002, 16814153.
34. Hall EJ. Intensity-modulated radiation therapy, protons, and the risk of second cancers. Int J Radiat Oncol Biol Phys 2006, 65:1-7.
35. Hall EJ, Wuu CS. Radiation-induced second cancers: the impact of 3D-CRT and IMRT. Int J Radiat Oncol Biol Phys 2003, 56:83-88.
36. Dorr W, Herrmann T. Second primary tumors after radiotherapy for malignancies. Treatment-related parameters. Strahlenther Onkol 2002, 178:357-362. 10.1007/s00066-002-0951-6, 12163989.